EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
6.3.2.17 | ADP + methotrexate-Glu3 + phosphate |
- |
Homo sapiens |
ATP + methotrexate-Glu2 + L-glutamate |
- |
? |
6.3.2.17 | ADP + methotrexate-Glu4 + phosphate |
- |
Homo sapiens |
ATP + methotrexate-Glu3 + L-glutamate |
- |
? |
6.3.2.17 | ADP + phosphate + 7,8-dihydropteroyl-Glu |
- |
Mus musculus |
ATP + 7,8-dihydropteroate + L-glutamate |
- |
? |
6.3.2.17 | ADP + phosphate + 7,8-dihydropteroyl-Glu |
- |
Homo sapiens |
ATP + 7,8-dihydropteroate + L-glutamate |
- |
? |
6.3.2.17 | ATP + (2S)-2-(o-fluoro-p-(N-(2,7-dimethyl-4-oxo-3,4-dihydroquinazolin-6-yl)methyl)-N-(prop-2-ynyl-amino)benzamido)-4-(tetrazol-5-yl)butyric acid + L-glutamate |
- |
Homo sapiens |
ADP + (2S)-2-(o-fluoro-p-(N-(2,7-dimethyl-4-oxo-3,4-dihydroquinazolin-6-yl)methyl)-N-(prop-2-ynyl-amino)benzamido)-4-(tetrazol-5-yl)butanoyl-L-Glu + phosphate |
- |
? |
6.3.2.17 | ATP + (2S)-2-(o-fluoro-p-(N-(2,7-dimethyl-4-oxo-3,4-dihydroquinazolin-6-yl)methyl)-N-(prop-2-ynyl-amino)benzamido)-4-(tetrazol-5-yl)butyric acid + L-glutamate |
- |
Mus musculus |
ADP + (2S)-2-(o-fluoro-p-(N-(2,7-dimethyl-4-oxo-3,4-dihydroquinazolin-6-yl)methyl)-N-(prop-2-ynyl-amino)benzamido)-4-(tetrazol-5-yl)butanoyl-Glu + phosphate |
- |
? |
6.3.2.17 | ATP + (6R)-10-formyl-5,6,7,8-tetrahydropteroylglutamate + L-glutamate |
- |
Mus musculus |
ADP + phosphate + (6R)-10-formyl-5,6,7,8-tetrahydropteroyl-Glu2 |
- |
? |
6.3.2.17 | ATP + (6R)-5,10-methylene-5,6,7,8-tetrahydropteroyl-Glu + L-glutamate |
ATP in form of MgATP2- |
Lacticaseibacillus casei |
ADP + phosphate + (6R)-5,10-methylene-5,6,7,8-tetrahydropteroyl-Glu2 |
- |
? |
6.3.2.17 | ATP + (6R,S)-5,6,7,8-tetrahydrofolic acid + L-glutamate |
- |
Escherichia coli |
ADP + phosphate + (6S)-5,6,7,8-tetrahydrofolyl-gamma-Glu |
- |
ir |
6.3.2.17 | ATP + (6RS)-5,6,7,8-tetrahydrofolic acid + L-glutamate |
- |
Mycobacterium tuberculosis |
ADP + phosphate + (6S)-5,6,7,8-tetrahydrofolyl-Glu |
- |
ir |